Results

Total Results: 1,117 records

Showing results for "choice".

201. Nephropathy-Contrast-Induced Executive-2016 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/nephropathy-contrast-induced_executive-2016.pdf
     January 01, 2016 - For clinicians, these findings suggest that the choice between IOCM and LOCMs will not have an important … Choice of contrast medium in patients with impaired renal function undergoing percutaneous coronary

202. Cer-235-Pharma-Nonpharm-Ptsd-Update-Appendix-G-1 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-235-pharma-nonpharm-ptsd-update-appendix-g-1.xlsx
     November 12, 2020 - numbers table, coin toss No: • Alternation, case record #, birth days, week days • Participant/provider choice

203. Cer-235-Pharma-Nonpharm-Ptsd-Update-Appendix-G-1 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-235-pharma-nonpharm-ptsd-update-appendix-g-1.xlsx
     November 12, 2020 - numbers table, coin toss No: • Alternation, case record #, birth days, week days • Participant/provider choice

204. Methods Guide for Medical Test Reviews Chapter 3 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-outcomes_methods.pdf
     July 01, 2012 - role of stakeholders in reviews of medical tests, as their inputs are particularly relevant to the choice … It is likely, however, that the choice of outcomes depends largely on the needs of stakeholders and

205. 04-E029-1 Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-surveillance_executive.pdf
     December 01, 2011 - these men are monitored closely and treated with curative intent at signs of progression or patient choice … low-risk prostate cancer reported that physician description of prostate cancer affected treatment choice … We note that model based costs are sensitive to the model assumptions and choice of inputs. … for unbiased analyses, because patient characteristics are strongly associated with initial treatment choice

206. Allergen-Specific Immunotherapy for the Treatment of Allergic Rhinoconjunctivitis and/or Asthma: Comparative Effectiveness Review | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/asthma-immunotherapy-2010/research
     March 27, 2013 - Current Page Topic Timeline Sep. 3, 2009 Topic Suggestion Aug. 24, 2011 Research Protocol Mar. 27, 2013 Systematic Review Jul. 31, 2013 Disposition of Comments Report Allergen-Specific Immunotherapy for the Treatment of Allergic Rhinoconjunctivitis and/or Asthma: Comparative Effectiveness Review Systematic Review …

207. Back (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/back.pdf
     January 01, 2011 - Back Slide  1: Decision making  when clinical evidence  is limited: Palliative  chemotherapy  for cancer Anthony Back, MD University of Washington Fred  Hutchinson Cancer Research Center Seattle, Washington Slide  2: The  problem • 33 yo  man …

208. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_executive-2007.pdf
     January 01, 2007 - Layout 1 This report is an update to a Comparative Effectiveness Review on management strategies for renal artery stenosis (RAS) from October 2006. The systematic review included all studies of patients with atherosclerotic RAS (ARAS) that compared two or more interventions. It also reviewed recent prospective cohort…

209. S5 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s5.pdf
     October 01, 2007 - strategy for expanding methods for comparative effectiveness and safety analyses is to ex- pand the choice

210. Evidence-based Practice Center Systematic Review Protocol - Management of Infantile Epilepsies (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-252-infantile-epilepsies-disposition-comments.pdf
     October 25, 2022 - before surgery, in practice it is typically more, and current trends are to view as a treatment of choice … there is no discussion of, or reference to, the etiology of the seizure activity as pertinent to the choice … direct relationship between mitochondrial dysfunction or other genetic aberrations and anticonvulsant choice … ), and we assessed the risk of bias of studies in that context, we believe that cause is the best choice

211. Core-Needle Biopsy for Breast Abnormalities (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-biopsy-update_clinician.pdf
     May 01, 2016 - The size, location, or imaging characteristics of a lesion may influence the choice of one breast biopsy

212. Ced-Topic-Refinement (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ced-topic-refinement.pdf
     November 01, 2022 - We added: “If a contemporaneous comparison group is not included, this choice must be justified.” … If a contemporaneous comparison group is not included, this choice must be justified. … If a contemporaneous comparison group is not included, this choice must be justified. Design g. … If a contemporaneous comparison group is not included, this choice must be justified. 2.0 M. … If a contemporaneous comparison group is not included, this choice must be justified. 9 0 0 2.0 M.

213. Disposition of Comments Report for Imaging Techniques for the Diagnosis and Staging of Hepatocellular Carcinoma (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/liver-cancer_disposition-comments.pdf
     October 23, 2014 - In addition, decisions regarding choice of diagnostic tests to use in surveillance may depend on factors … In addition, decisions regarding choice of diagnostic tests to use in surveillance may depend on factors … In addition, decisions regarding choice of diagnostic tests to use in surveillance may depend on factors … In addition, decisions regarding choice of diagnostic tests to use in surveillance may depend on factors … In addition, decisions regarding choice of diagnostic tests to use in surveillance may depend on factors

214. Disposition of Comments Report for CER 226: Labor Dystocia (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-226-labor-dystocia-comments.pdf
     May 14, 2020 - Discrete choice experiments would be one method appropriate for estimating preferences for these complex … as part of labor management to either directly (artificial rupture of membranes) or indirectly (choice … as part of labor management to either directly (artificial rupture of membranes) or indirectly (choice … we have clarified that the report covers diagnosis, direct and indirect prevention (i.e., does choice

215. Primary Care Management of Abnormal Uterine Bleeding (AUB) | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/abnormal-uterine-bleeding/research-protocol
     November 21, 2011 - Over time, differences in terminology choice and in operational definitions resulted in wide inconsistencies … noncontraceptive uses of hormonal contraceptives recommends combined oral contraceptives as a reasonable choice

216. Long-Term-Care-Adults Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/long-term-care-adults_executive.pdf
     November 01, 2012 - For older adults who need LTC, the choice of one form of care over the other requires a careful evaluation … Further, the settings where individuals receive LTC may not reflect personal choice or fit, but instead

217. Topic 0494 Tacrolimus Monitoring and Treatment Renal Transplantation NSD FINAL (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0583-131115.pdf
     March 13, 2013 - Topic 0494 Tacrolimus Monitoring and Treatment Renal Transplantation NSD FINAL Calcineurin Inhibitor Minimization, Withdrawal, and Avoidance…

218. Epstein (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/epstein.pdf
     January 01, 2011 - Epstein Slide  1: What is shared in shared decision-­‐making? Eliciting and constructing patients’ preferences when the evidence is unclear Ronald M Epstein MD Professor of Family Medicine, Psychiatry, Oncology and  Nursing Director, Center for Communication and Disparities Resear…

219. PATIENTSLIKEME (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/clifford.pdf
     January 06, 2017 - PATIENTSLIKEME INNOVATIONS CONFERENCE -- PATIENTSLIKEME SPEAKER: DAVE CLIFFORD, HEAD OF PUBLIC HEALTH AND GOVERNMENT AFFAIRS, PATIENTSLIKEME CLIFFORD: Hi. I'm Dave Clifford from PatientsLikeMe. I'm gonna talk about patient value in online communities a bit from our experie…

220. Breast-Cancer-Medications Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-cancer-medications_surveillance.pdf
     July 01, 2012 - What is the evidence that harms or secondary potential benefits listed above affect treatment choice, … Up-to-date Up-to-date Studies of treatment choice and concordance for raloxifene and tibolone … What is the evidence that harms or secondary potential benefits listed above affect treatment choice, … What is the evidence that harms or secondary potential benefits listed above affect treatment choice, … New Evidence: Studies of treatment choice and concordance for raloxifene and tibolone